Anika Therapeutics Inc
ANIK10.460USD
+0.160+1.55%
Handelsschluss 02/06, 16:00（ET）Kurse um 15 Minuten verzögert
150.84MMarktkapitalisierung
VerlustKGV TTM
mehr Informationen über Anika Therapeutics Inc Unternehmen
Anika Therapeutics, Inc. is engaged in the osteoarthritis pain management and regenerative solutions space focused on early intervention orthopedics. The Company is leveraging its core expertise in hyaluronic acid and implant solutions. It partners with clinicians to provide minimally invasive products that restore active living for people around the world. It is developing, manufacturing and commercializing products on its hyaluronic acid (HA) technology platform. It is focused on spaces within orthopedics, including osteoarthritis pain management and regenerative solutions, and its products are delivered in key sites of care, including ambulatory surgery centers. Its products include OA Pain Management, Regenerative Solutions, and others. The OA Pain Management product family consists of Cingal, Monovisc, Orthovisc, Orthovisc mini and Orthovisc-T. Its Regenerative Solutions include Integrity, Hyalofast, Tactoset and NanoFx.
Anika Therapeutics Inc Informationen
BörsenkürzelANIK
Name des UnternehmensAnika Therapeutics Inc
IPO-datumMay 16, 1985
CEOBlanchard (Cheryl Renee)
Anzahl der mitarbeiter288
WertpapierartOrdinary Share
GeschäftsjahresendeMay 16
Addresse32 Wiggins Ave
StadtBEDFORD
BörseNASDAQ OMX - NASDAQ BASIC
LandUnited States of America
Postleitzahl01730-2315
Telefon17814579000
Websitehttps://anika.com/
BörsenkürzelANIK
IPO-datumMay 16, 1985
CEOBlanchard (Cheryl Renee)
Führungskräfte von Anika Therapeutics Inc
Name
Name/Position
Position
Aktienbesitz
Veränderung
Dr. Glenn R. Larsen, Ph.D.
Dr. Glenn R. Larsen, Ph.D.
Independent Director
Independent Director
50.26K
+14164.00%
Ms. Sheryl L. Conley
Ms. Sheryl L. Conley
Independent Director
Independent Director
39.84K
+14164.00%
Mr. William R. (Bill) Jellison
Mr. William R. (Bill) Jellison
Independent Director
Independent Director
23.10K
+14164.00%
Mr. Joseph H. (Joe) Capper
Mr. Joseph H. (Joe) Capper
Independent Director
Independent Director
20.40K
+14164.00%
Mr. Stephen D. (Steve) Griffin
Mr. Stephen D. (Steve) Griffin
Chief Financial Officer, Chief Operating Officer, Executive Vice President
Chief Financial Officer, Chief Operating Officer, Executive Vice President
9.07K
+9071.00%
Dr. Cheryl Renee Blanchard, Ph.D.
Dr. Cheryl Renee Blanchard, Ph.D.
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
--
--
Ms. Susan L. N. Vogt
Ms. Susan L. N. Vogt
Independent Director
Independent Director
--
--
Mr. David B. Colleran, J.D.
Mr. David B. Colleran, J.D.
Executive Vice President, General Counsel, Secretary
Executive Vice President, General Counsel, Secretary
--
--
Mr. John Bell (Jack) Henneman, III
Mr. John Bell (Jack) Henneman, III
Independent Chairman of the Board
Independent Chairman of the Board
--
--
Mr. Stephen O. Richard
Mr. Stephen O. Richard
Independent Director
Independent Director
--
--
Mehr Anzeigen
Name
Name/Position
Position
Aktienbesitz
Veränderung
Dr. Glenn R. Larsen, Ph.D.
Dr. Glenn R. Larsen, Ph.D.
Independent Director
Independent Director
50.26K
+14164.00%
Ms. Sheryl L. Conley
Ms. Sheryl L. Conley
Independent Director
Independent Director
39.84K
+14164.00%
Mr. William R. (Bill) Jellison
Mr. William R. (Bill) Jellison
Independent Director
Independent Director
23.10K
+14164.00%
Mr. Joseph H. (Joe) Capper
Mr. Joseph H. (Joe) Capper
Independent Director
Independent Director
20.40K
+14164.00%
Mr. Stephen D. (Steve) Griffin
Mr. Stephen D. (Steve) Griffin
Chief Financial Officer, Chief Operating Officer, Executive Vice President
Chief Financial Officer, Chief Operating Officer, Executive Vice President
9.07K
+9071.00%
Dr. Cheryl Renee Blanchard, Ph.D.
Dr. Cheryl Renee Blanchard, Ph.D.
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
--
--
Umsatzaufteilung
Währung: USDAktualisiert: Tue, Jan 6
Währung: USDAktualisiert: Tue, Jan 6
FY2025Q3
FY2025Q2
FY2025Q1
FY2024
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022
FY2022Q4
FY2022Q3
FY2022Q2
FY2022Q1
FY2021
FY2020
FY2019
FY2018
Nach GeschäftsbereichUSD
Name
Umsatz
Anteil
OEM Channel
15.84M
56.96%
Commercial Channel
11.97M
43.04%
Nach RegionUSD
Name
Umsatz
Anteil
United States
17.45M
62.72%
Europe
5.67M
20.38%
Other
4.70M
16.91%
Nach Geschäftsbereich
Nach Region
Nach GeschäftsbereichUSD
Name
Umsatz
Anteil
OEM Channel
15.84M
56.96%
Commercial Channel
11.97M
43.04%
Aktionärsstatistik
Aktualisiert: Sat, Feb 7
Aktualisiert: Sat, Feb 7
Aktionäre
Aktionärstypen
Aktionäre
Aktionäre
Anteil
Caligan Partners, LP
9.95%
BlackRock Institutional Trust Company, N.A.
6.38%
The Vanguard Group, Inc.
5.40%
BlackRock Financial Management, Inc.
5.38%
Acadian Asset Management LLC
4.39%
Andere
68.49%
Aktionäre
Aktionäre
Anteil
Caligan Partners, LP
9.95%
BlackRock Institutional Trust Company, N.A.
6.38%
The Vanguard Group, Inc.
5.40%
BlackRock Financial Management, Inc.
5.38%
Acadian Asset Management LLC
4.39%
Andere
68.49%
Aktionärstypen
Aktionäre
Anteil
Investment Advisor/Hedge Fund
27.66%
Investment Advisor
25.57%
Hedge Fund
20.33%
Individual Investor
4.88%
Research Firm
2.02%
Pension Fund
0.52%
Bank and Trust
0.11%
Venture Capital
0.09%
Andere
18.81%
Institutionelle Beteiligung
Aktualisiert: Mon, Dec 8
Aktualisiert: Mon, Dec 8
Berichtszeitraum
Anzahl der Institutionen
Gehaltenen Aktien
Anteil
Veränderung
2025Q4
245
12.37M
97.19%
-666.00
2025Q3
267
12.37M
100.32%
-461.27K
2025Q2
295
12.88M
103.23%
-71.30K
2025Q1
297
12.95M
103.38%
-1.70M
2024Q4
298
12.83M
102.20%
-560.99K
2024Q3
297
13.48M
104.72%
-150.44K
2024Q2
301
13.64M
105.78%
+30.78K
2024Q1
301
13.61M
105.08%
-1.78M
2023Q4
304
13.45M
105.34%
+303.47K
2023Q3
297
13.16M
105.14%
-356.42K
Mehr Anzeigen
Aktionärsaktivitäten
Name
Gehaltenen Aktien
Anteil
Veränderung
Änderung%
Datum
Caligan Partners, LP
1.44M
9.95%
--
--
Nov 19, 2025
BlackRock Institutional Trust Company, N.A.
920.60K
6.38%
-16.70K
-1.78%
Sep 30, 2025
The Vanguard Group, Inc.
780.66K
5.41%
+1.19K
+0.15%
Sep 30, 2025
BlackRock Financial Management, Inc.
776.43K
5.38%
+230.31K
+42.17%
Sep 30, 2025
Acadian Asset Management LLC
632.79K
4.39%
+57.15K
+9.93%
Sep 30, 2025
Dimensional Fund Advisors, L.P.
601.16K
4.17%
-21.92K
-3.52%
Sep 30, 2025
Boothbay Fund Management, LLC
539.64K
3.74%
+10.14K
+1.91%
Sep 30, 2025
Renaissance Technologies LLC
533.02K
3.7%
+5.80K
+1.10%
Sep 30, 2025
The Capital Management Corporation
551.25K
3.82%
+142.40K
+34.83%
Sep 30, 2025
Geode Capital Management, L.L.C.
335.68K
2.33%
+14.47K
+4.50%
Sep 30, 2025
Mehr Anzeigen
Verbundene ETFs
Aktualisiert: Sat, Dec 6
Aktualisiert: Sat, Dec 6
Name
Anteil
Invesco NASDAQ Future Gen 200 ETF
0.56%
Royce Quant Small-Cap Quality Value ETF
0.2%
SPDR SSGA US Small Cap Low Volatility Index ETF
0.1%
iShares Micro-Cap ETF
0.02%
Goldman Sachs ActiveBeta US Small Cap Equity ETF
0.02%
JPMorgan Diversified Return U.S. Small Cap Equity ETF
0.01%
Avantis US Small Cap Equity ETF
0.01%
Invesco RAFI US 1500 Small-Mid ETF
0.01%
WisdomTree US SmallCap Fund
0.01%
iShares Russell 2000 Value ETF
0.01%
Mehr Anzeigen
Invesco NASDAQ Future Gen 200 ETF
Anteil0.56%
Royce Quant Small-Cap Quality Value ETF
Anteil0.2%
SPDR SSGA US Small Cap Low Volatility Index ETF
Anteil0.1%
iShares Micro-Cap ETF
Anteil0.02%
Goldman Sachs ActiveBeta US Small Cap Equity ETF
Anteil0.02%
JPMorgan Diversified Return U.S. Small Cap Equity ETF
Anteil0.01%
Avantis US Small Cap Equity ETF
Anteil0.01%
Invesco RAFI US 1500 Small-Mid ETF
Anteil0.01%
WisdomTree US SmallCap Fund
Anteil0.01%
iShares Russell 2000 Value ETF
Anteil0.01%
Dividende
In den vergangenen 5 Jahren wurden insgesamt
0.00
USD an Dividenden ausgeschüttet.
Datum
Dividende
Stichtag für die Aktienregistrierung
Zahltag
Ex-Dividendentag
Keine Daten
Aktien-Split
Datum
Ex-Dividendentag
Art
Verhältnis
Keine Daten
Datum
Ex-Dividendentag
Art
Verhältnis
Keine Daten
